Legal & General Group PLC Guardant Health, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 195,489 shares of GH stock, worth $5.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

195,489

Previous 195,489 -0.0%

Holding current value

$5.69 Million

Previous $4.48 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $278,973 - $453,987	12,510 Added 6.84%	195,489 $4.48 Million
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $12,020 - $23,816	748 Added 0.41%	182,979 $5.28 Million
Q1 2024 May 14, 2024	BUY	$17.13 - $26.91 $386,041 - $606,443	22,536 Added 14.11%	182,231 $3.76 Million
Q4 2023 Feb 15, 2024	SELL	$21.58 - $29.5 $141,651 - $193,638	-6,564 Reduced 3.95%	159,695 $4.32 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $278,407 - $431,316	-10,791 Reduced 6.09%	166,259 $4.93 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $526,515 - $955,723	25,144 Added 16.55%	177,050 $6.34 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $746,046 - $1.1 Million	32,550 Added 27.27%	151,906 $3.56 Million
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $101,887 - $239,418	-4,005 Reduced 3.25%	119,356 $3.25 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $722,573 - $1.01 Million	-16,550 Reduced 11.83%	123,361 $6.64 Million
Q2 2022 Aug 22, 2022	BUY	$28.82 - $77.35 $562,796 - $1.51 Million	19,528 Added 16.22%	139,911 $5.64 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $531,087 - $1.11 Million	11,007 Added 10.06%	120,383 $7.97 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $2.32 Million - $3.14 Million	26,114 Added 31.36%	109,376 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $1.8 Million - $2.41 Million	18,243 Added 28.06%	83,262 $10.4 Million
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $83,864 - $126,579	764 Added 1.19%	65,019 $8.08 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $694,146 - $978,602	5,464 Added 9.29%	64,255 $9.81 Million
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $57,576 - $78,295	-576 Reduced 0.97%	58,791 $7.58 Million
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $19,999 - $27,838	-249 Reduced 0.42%	59,367 $6.64 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $1.83 Million - $2.95 Million	30,233 Added 102.89%	59,616 $4.84 Million
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $30,818 - $46,358	522 Added 1.81%	29,383 $2.05 Million
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $303,280 - $422,012	5,098 Added 21.45%	28,861 $2.26 Million
Q3 2019 Nov 13, 2019	BUY	$62.59 - $110.3 $280,528 - $494,364	4,482 Added 23.25%	23,763 $1.52 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $56,650 - $80,723	886 Added 4.82%	19,281 $1.66 Million
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $553,636 - $1.58 Million	16,141 Added 716.1%	18,395 $1.41 Million
Q4 2018 Feb 15, 2019	BUY	$29.2 - $46.1 $65,816 - $103,909	2,254 New	2,254 $85,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.98B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Guardant Health, Inc. Transaction History